Sexual dysfunction in diabetes

Handbook of Clinical Neurology

Volumn 126, Issue , 2014, Pages 223-232

  Tamás, Várkonyi ^a   Kempler, Peter ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Artery size hypothesis; Erectile dysfunction; Phosphodiesterase 5 inhibitors; Princeton guidelines; Sexual dysfunction

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ANIMAL; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DRUG EFFECTS; ERECTILE DYSFUNCTION; FEMALE; HUMAN; MALE; PHYSIOLOGY; PROCEDURES; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84921986303     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53480-4.00017-5     Document Type: Chapter

References (81)

1. Althof S.E., Rosen R.C., DeRogatis L., et al. Outcome measurement in female sexual dysfunction clinical trials: review and recommendations. J Sex Marital Ther 2005, 31:153-166.
2. Andersson K.E. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev 2011, 63:811-859.
3. Aslan E., Fynes M. Female sexual dysfunction. Int Urogynecol J 2008, 19:293-305.
4. Awad H., Salem A., Gadalla A., et al. Erectile function in men with diabetes type 2: correlation with glycemic control. Int J Impot Res 2010, 22:36-39.
5. Banks E., Joshy G., Abhayaratna W.P., et al. Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study. PLoS Med 2013, 10:e1001372.
6. Basu A., Ryder R.E. New treatment options for erectile dysfunction in patients with diabetes mellitus. Drugs 2004, 64:2667-2688.
7. Bernini G.P., Lucarini A.R., Franchi F., et al. Humoral effects of metoclopramide and domperidone in normal subjects and in hypertensive patients. J Endocrinol Invest 1988, 11:711-716.
8. Bishop J.R., Moul J.W., Sihelnik S.A., et al. Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. J Urol 1992, 147:386-388.
9. Bleustein C.B., Arezzo J.C., Eckholdt H., et al. The neuropathy of erectile dysfunction. Int J Impot Res 2002, 14:433-439.
10. Boulton A.J., Selam J.L., Sweeney M., Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia 2001, 44:1296-1301.
11. Burke J.P., Jacobson D.J., McGree M.E., et al. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. J Urol 2007, 177:1438-1442.
12. Buvat J., van Ahlen H., Schmitt H., et al. Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries. J Sex Med 2006, 3:512-520.
13. Cameron N.E., Cotter M.A. Erectile dysfunction and diabetes mellitus: mechanistic considerations from studies in experimental models. Curr Diabetes Rev 2007, 3:149-158.
14. Cartledge J.J., Eardley I., Morrison J.F. Advanced glycation endproducts are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. BJU Int 2001, 87:402-407.
15. Corona G., Mannucci E., Mansani R., et al. Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. Eur Urol 2004, 46:222-228.
16. Corona G., Mannucci E., Forti G., et al. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?. Int J Androl 2009, 32:431-441.
17. Corona G., Giorda C.B., Cucinotta D., et al. The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients. J Endocrinol Invest 2013, 36:864-868.
18. De Angelis L., Marfella M.A., Siniscalchi M., et al. Erectile and endothelial dysfunction in type II diabetes: a possible link. Diabetologia 2001, 44:1155-1160.
19. Eardley I., Lee J.C., Shabsigh R., et al. Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications. J Sex Med 2010, 7:244-255.
20. Enzlin P., Mathieu C., Van den Bruel A., et al. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care 2002, 25:672-677.
21. Enzlin P., Rosen R., Wiegel M., et al. Sexual dysfunction in women with type 1 diabetes. Diabetes Care 2009, 32:780-785.
22. Esposito K., Maiorino M.I., Bellastella G., et al. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res 2010, 22:179-184.
23. Fatemi S.S., Taghavi S.M. Evaluation of sexual function in women with type 2 diabetes mellitus. Diab Vasc Dis Res 2009, 6:38-39.
24. Fonseca V., Seftel A., Denne J., et al. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 2004, 47:1914-1923.
25. Francis M.E., Kusek J.W., Nyberg L., et al. The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males. J Urol 2007, 178:591-596.
26. Giraldi A., Kristensen E. Sexual dysfunction in women with diabetes mellitus. J Sex Res 2010, 47:199-211.
27. Goldstein I., Young J.M., Fischer J., et al. Vardenafil, a new phosphodiesterase type 5 inhibitor in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 2003, 26:777-783.
28. Greco E.A., Spera G., Aversa A. Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences. Eur Urol 2006, 50:940-947.
29. Grover-Páez F., Rivera G.V., Ortíz R.G. Sildenafil citrate diminishes microalbuminuria and the percentage of A1c in male patients with type 2 diabetes. Diabetes Res Clin Pract 2007, 78:136-140.
30. Guay A.T. Relation of endothelial cell function to erectile dysfunction: implications for treatment. Am J Cardiol 2005, 96(suppl):52M-56M.
31. Hackett G., Cole N., Bhartia M., et al. Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes. J Sex Med 2013, 10:1612-1627.
32. Hamdan F.B., Al-Matubsi H.Y. Assessment of erectile dysfunction in diabetic patients. Int J Androl 2009, 32:176-185.
33. Hatzichristou D., Gambla M., Rubio-Aurioles E., et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med 2008, 25:138-146.
34. Hatzimouratidis K., Hatzichristou D.G. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?. Drugs 2005, 65:1621-1650.
35. Heaton J.P., Lording D., Liu S.N., et al. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. Int J Impot Res 2001, 13:317-321.
36. Ishii N., Nagao K., Fujikawa K.T., et al. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction. Int J Urol 2006, 3:1066-1072.
37. Israilov S., Shmuely J., Niv E., et al. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2005, 17:431-436.
38. Jackson G. Erectile dysfunction and cardiovascular disease. Int J Clin Pract 1999, 53:363-368.
39. Jacobson A.M., Braffett B.H., Cleary P.A., et al. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort. Diabetes Care 2013, 36:3131-3138.
40. Jansson P.A., Murdolo G., Sjögren L., et al. Tadalafil increases muscle capillary recruitment and forearm glucose uptake in women with type 2 diabetes. Diabetologia 2010, 53:2205-2208.
41. Kalter-Leibovici O., Wainstein J., Ziv A., et al. Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men. Diabetes Care 2005, 28:739-1744.
42. Kelley S.R., Kamal T.J., Molitch M.E. Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia. Am J Physiol 1996, 270:96-100.
43. Khatana S.A.M., Taveira T.H., Miner M.M., et al. Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus?. Int J Impot Res 2008, 20:501-506.
44. Kostis J.B., Jackson G., Rosen R., et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005, 96:313-321.
45. Malavige L.S., Levy J.C. Erectile dysfunction in diabetes mellitus. J Sex Med 2009, 6:1232-1247.
46. Meller S.M., Stilp E., Walker C.N., et al. The link between vasculogenic erectile dysfunction, coronary artery disease, and peripheral artery disease: role of metabolic factors and endovascular therapy. J Invasive Cardiol 2013, 25:313-319.
47. Miralles-García J.M., García-Díez L.C. Specific aspects of erectile dysfunction in endocrinology. Int J Impot Res 2004, 16(Suppl 2):S10-S12.
48. Montorsi P., Ravagnani P.M., Galli S., et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005, 96:19-23.
49. Nicolosi A., Glasser D.B., Brock G., et al. Diabetes and sexual function in older adults: results of an international survey. Br J Diabetes Vasc Dis 2002, 2:336-339.
50. Nowosielski K., Drosdzol A., Sipiński A., et al. Diabetes mellitus and sexuality - does it really matter?. J Sex Med 2010, 7:723-735.
51. Omrod D., Easthope S.E., Figgitt D. Vardenafil. Drugs Aging 2002, 19:217-227.
52. Pegge N.C., Twomey A.M., Vaughton K., et al. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment. Diabet Med 2006, 23:873-878.
53. Penson D.F., Wessells H., Cleary P., et al. Sexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort. J Sex Med 2009, 6:1969-1978.
54. Perimenis P., Konstantinopoulos A., Perimeni P.P., et al. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction. Asian J Androl 2006, 8:219-224.
55. Reffelmann T., Kloner R.A. Sexual function in hypertensive patients receiving treatment. Vasc Health Risk Manag 2006, 2:447-455.
56. Rendell M.S., Rajfer J., Wicker P.A., et al. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 1999, 281:421-426.
57. Richardson D., Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep 2002, 2:501-509.
58. Romeo J.H., Seftel A.D., Madhun Z.T., et al. Sexual function in men with diabetes type 2: association with glycemic control. J Urol 2000, 163:788-791.
59. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49:822-830.
60. Rosen R.C., Friedman M., Kostis J.B. Lifestyle management of erectile dysfunction: the role of cardiovascular and concomitant risk factors. Am J Cardiol 2005, 96(Suppl):76M-79M.
61. Saenz de Tejada I., Moroukian P., Tessier J., et al. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989, 320:1025-1030.
62. Sáenz de Tejada I., Anglin G., Knight J.R., Emmick J.T. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 2002, 25:2159-2164.
63. Safarinejad M.R. Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study. J Diabetes Complications 2004, 18:205-210.
64. Schwarz E.R., Kapur V., Rodriguez J., et al. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. Int J Impot Res 2007, 19:139-148.
65. Song W.D., Yuan Y.M., Cui W.S., et al. Penile prosthesis implantation in Chinese patients with severe erectile dysfunction: 10-year experience. Asian J Androl 2013, 15:658-661.
66. Stirban A., Laude D., Elghozi J.L., et al. Acute effects of sildenafil on flow mediated dilatation and cardiovascular autonomic nerve function in type 2 diabetic patients. Diabetes Metab Res Rev 2009, 25:136-143.
67. Stuckey B.G., Jadzinsky M.N., Murphy L.J., et al. Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care 2003, 26:279-284.
68. Sun P., Cameron A., Seftel A., et al. Erectile dysfunction - an observable marker of diabetes mellitus? A large national epidemiological study. J Urol 2006, 176:1081-1085.
69. Tesfaye S., Stevens L.K., Stephenson J.M., et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996, 39:1377-1384.
70. Thorve V.S., Kshirsagar A.D., Vyawahare N.S., et al. Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complications 2011, 25:129-136.
71. Tripathy D., Dhindsa S., Garg R. Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect?. Metab Syndr Relat Disord 2003, 1:75-80.
72. Vardi Y. Microvascular complications in diabetic erectile dysfunction: do we need other alternatives?. Diabetes Care 2009, 32(Suppl 2):S420-S422.
73. Vardi Y., Sprecher E., Kanter Y., et al. Polyneuropathy in impotence. Int J Impot Res 1996, 8:65-68.
74. Várkonyi T., Kempler P. Erectile dysfunction. Diabetes in Old Age 2009, 149-164. John Wiley & Sons, Chichester. 3rd edn. A. Sinclair (Ed.).
75. Vickers M., Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2002, 14:466-471.
76. Vickers M.A., Wright E.A. Erectile dysfunction in the patient with diabetes mellitus. Am J Manag Care 2004, 10(Suppl 1):3-11.
77. Vinik A.I., Maser R.E., Mitchell B.D., et al. Diabetic autonomic neuropathy. Diabetes Care 2003, 26:1553-1579.
78. Wandell P.E., Brorsson B. Assessing sexual functioning in patients with chronic disorders by using a generic health-related quality of life questionnaire. Qual Life Res 2000, 9:1081-1092.
79. Wellmer A., Sharief M.K., Knowles C.H., et al. Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction. BJU Int 1999, 83:66-70.
80. Wilson S.K., Carson C.C., Cleves M.A., et al. Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol 1998, 159:1537-1539.
81. Ziegler D., Merfort F., van Ahlen H., et al. Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction. J Sex Med 2006, 3:883-891.